Eurofins Selcia

Selcia, now part of Eurofins, is a global leader in 14C custom radiolabelling, stable isotope labelling and analytical services. With many years of experience our team of expert synthetic radiochemists can prepare radiolabelled molecules of almost any complexity for use in regulatory studies by the life sciences and chemical industries to understand: preclinical and clinical drug metabolism, human mass balance (GMP 14C Radiolabelled API), dermal penetration, tissue distribution and environmental fate. Selcia also offers GLP NMR and analytical problem solving services to support regulatory submissions, as well as the profiling and synthesis of metabolites and process impurities. 14C Custom Radiolabelling...

Adme,14c custom radiosynthesis,pharmacology,gmp radiolabelled api for clinical trials,glp/gmp analytics,stable labelled compounds,metabolites and impurities profiling and synthesis,and analytical standards

Eurofins selcia operates in the Pharmaceutical manufacturing industry.

Eurofins selcia's revenue is 11m - 100m

Eurofins selcia has 51 - 200 employees.